Xenon Pharmaceuticals XENE
NASDAQ XENE
$35.24 -1.26 (-3.44%)
As of: Oct 23, 2026 · 3:59 PM EDT

Xenon Pharmaceuticals (XENE) Cash & Current Investments (2013 - 2026)

Updated

Xenon Pharmaceuticals (XENE) recorded Cash & Current Investments of $930.69 million in Q2 2026, up 90.9% from $487.55 million a year earlier but down 15.0% from the prior quarter.

Analysis

Xenon Pharmaceuticals (XENE) Cash & Current Investments (2013 - 2026) Analysis & Trends

At the end of FY2025, Xenon Pharmaceuticals reported Cash & Current Investments of $548.89 million, down 12.4% from FY2024.

  • Annual Cash & Current Investments has a five-year compound annual growth rate of 25.4% (FY2020 to FY2025).
  • Across earlier years, Cash & Current Investments came in at $626.91 million in FY2024 (-1.8%), $638.08 million in FY2023 (+7.8%), $592.09 million in FY2022 (+7.3%) and $551.77 million in FY2021 (+211.7%).
  • Quarterly Cash & Current Investments has ranged from $249.63 million in Q3 2021 to $1.09 billion in Q1 2026 over the past five years.
  • On a year-over-year basis, Cash & Current Investments rose in three of the last eight quarters, with growth averaging 14.6%.
  • Peak year-over-year performance for Cash & Current Investments in the last five years was growth of 211.7% in Q4 2021, against a decline of 32.4% in Q2 2025 at the low end.
  • Per Business Quant, the preceding three quarters came in at $1.09 billion (Q1 2026), $548.89 million (Q4 2025) and $462.27 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn 17.23 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn 6.57 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn 7.69 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn 4.90 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 3.18 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 11.70 Bn
10 Xenon Pharmaceuticals 3.53 Bn 493.58 Mn - 930.69 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 930.69 Mn
Mar 31, 2026 1.09 Bn
Dec 31, 2025 548.89 Mn
Sep 30, 2025 462.27 Mn
Jun 30, 2025 487.55 Mn
Mar 31, 2025 549.63 Mn
Dec 31, 2024 626.91 Mn
Sep 30, 2024 654.02 Mn
Jun 30, 2024 721.54 Mn
Mar 31, 2024 699.60 Mn
Dec 31, 2023 638.08 Mn
Sep 30, 2023 526.67 Mn
Jun 30, 2023 539.60 Mn
Mar 31, 2023 527.04 Mn
Dec 31, 2022 592.09 Mn
Sep 30, 2022 638.19 Mn
Jun 30, 2022 788.24 Mn
Mar 31, 2022 537.94 Mn
Dec 31, 2021 551.77 Mn
Sep 30, 2021 249.63 Mn
API Access

Xenon Pharmaceuticals Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=XENE&period=max&api_key=YOUR_API_KEY